Brightsurf Science News & Current Events

October 01, 1999
Normal cellular enzyme becomes marker for Alzheimer's disease
Scientists funded by the National Institutes of Health have discovered a new molecular marker for Alzheimer's disease -- a normal cellular protein called casein kinase-1 -- that piles up in nerve cells ravaged by the disease.

Researchers identify enzyme essential for battle against bacteria in the intestine
Researchers have identified an enzyme essential for the body's daily battle against bacteria in the intestine and possibly in other organs such as the lung and bladder.

3D circuits -- changing the shape of things to come
A new technology that allows 3-D electronic circuits to be moulded into plastic objects is set to change the shape of tomorrow's technology by allowing designers much greater freedom and providing excellent weight and space savings.

Reducing your risk of breast and ovarian cancer topic of women's cancer conference
More than 175,000 new cases of breast cancer and 25,000 cases of ovarian cancer will be diagnosed in American women this year, according to the American Cancer Society.

It's high time we registered all clinical trials say editors of Lancet and BMJ
The public has a right to know what medical research is being funded, argue the editors of the Lancet and the BMJ in a joint editorial published in this week's issues.

False teeth delivering drugs to infected mouths
False teeth smeared with a new biocompatible gel that contains molecules of medicinal drugs could revolutionise the treatment of denture stomatitis, a disease affecting up to two thirds of denture wearers, and oral infections such as Candida albicans.

New nasal obstruction procedure offers cheaper, pain-free alternative to surgery
An ear, nose and throat doctor at the University of North Carolina-Chapel Hill is using a new technology that has already proven successful in treating snoring to provide a less expensive, relatively pain-free alternative to traditional nasal obstruction surgery.

Researchers solve vision mystery
Researchers at The Hospital for Sick Children, McMaster University and the University of Toronto have unravelled the mystery of what causes the vision of human babies to improve so rapidly after birth.

Researchers find elevated cholesterol is risk factor for preeclampsia
A research team from the Massachusetts General Hospital (MGH) and Brigham and Women's (BWH) hospital has found that elevated cholesterol levels appear to be a risk factor for preeclampsia, a condition of pregnancy that can have dangerous consequences for both the mother and child.

Claims of cardiovascular benefits of HRT may be premature
It is too early to recommend hormone replacement therapy (HRT) for the prevention of cardiovascular disease.

Researchers discover location of a testicular cancer gene
A research team at Case Western Reserve University has discovered the first link to a gene controlling inherited susceptibility to testicular cancer -- the most common tumor affecting young men and one of the most readily treated cancers.

Breast cancer relapse rates appear higher in women who have cancer-causing gene, Yale study finds
A breast cancer study by Yale School of Medicine researcher Bruce G.

NRC mobilizes Canadian team to investigate Taiwan quake damage
The purpose of the mission is to gather perishable data and evidence that will be shared and used by scientists in Taiwan and in Canada.

First results of male osteoporosis treatment study
A drug used for treatment of osteoporosis in women has been shown to also be effective in men.

Rett Syndrome traced to defective gene 'silencer'
Rett syndrome is one of the most common forms of mental retardation in females.

Scientists discover new candidate drugs for treating HIV infection
Scientists have achieved a major step toward finding a new class of oral drugs to treat HIV infection.

IFT unmasks Halloween candy ingredients
Butylated hydroxyanisole. Invertase. Glycerol monostearate. Trick or treat? Though some candy ingredients may look or sound scary, there is nothing ghoulish about them.

Alcohol researchers confirm molecular culprit of alcohol-induced liver damage
A study reported in the October issue of Gastroenterology (Volume 177, pages 1-12) shows that tumor necrosis factor- alpha (TNF-alpha), a pro-inflammatory protein, plays an important role in the development of early liver damage associated with alcohol consumption.

Study confirms protein culprit in alcohol-induced liver disease
For the first time, scientists at the University of North Carolina at Chapel Hill have used gene knockout technology to firmly identify a key molecular player in alcohol-induced liver disease.

Peering into the amazing mind behind those baby blue eyes
The next time you glance at a baby in a crib, appreciate the fact that you are looking at more than just another cute face.

Getting your teeth into superplastic forming
Complete dental prostheses that are lighter, better fitting and more comfortable than traditional prostheses have been developed by a research team at King's College in London, UK, using an industrial process called superplastic forming.

NSF awards large grant for Arabidopsis information resource
By the end of next year, scientists will likely know the entire genetic makeup of the Arabidopsis thaliana plant, a mustard that is closely related to many food plants and used as a model for all aspects of plant biology.

New drugs target HIV's deep pocket
Earlier this week, a team of HHMI investigators reported that it had successfully attacked HIV in a newly targeted weak spot.

Some Neanderthals practiced cannibalism, shows find from French cave, as reported in the 1 October issue of Science
The best evidence yet that some members of a now-extinct species of human, the Neanderthals, practiced cannibalism has emerged at a cave site in France's Ard├Ęche region.

Jefferson scientists propose mechanism to control the body's red blood cell and platelet production
Researchers at Jefferson Medical College have uncovered a potential switch that helps control the manufacture of red blood cells and blood-clotting platelets.

Researchers join with treatment providers to improve drug abuse treatment
Researchers in Oregon have been awarded part of a $55 million grant from the National Institute on Drug Abuse to work with treatment providers on improved treatment. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to